PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse

Current Cancer Drug Targets

  • h-index: 111
  • Total citations: 61,196
  • Total papers: 1,667
  • Impact factor: 2.56

Homepage: http://www.benthamscience.com/ccdt/index.htm

Current Cancer Drug Targets

Journal
Visit website →
H-Index = 111
Citations = 61.20K+

Papers

Evidence

Recent papers in Current Cancer Drug Targets

  1. Clinicopathological Profiles and Prognosis of Postoperative HER2-Mutant Non-Small Cell Lung Cancer: A Real-World AnalysisCurrent Cancer Drug Targets · Mon,
  2. Multi-omics Signature Predicts Anti-EGFR Therapy Benefit in Colorectal Cancer Liver Metastases: A Multi-center Cohort StudyCurrent Cancer Drug Targets · Tue,
  3. Coordinated Roles of T Cells and Natural Killer Cells in Tumor ImmunityCurrent Cancer Drug Targets · Tue,
  4. Anticancer Effect and Mechanism of Novel c-Myc Inhibitor BP1 onHepatocellular CarcinomaCurrent Cancer Drug Targets · Tue,
  5. Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug TargetsCurrent Cancer Drug Targets · Tue,
  6. Targeting the Tumor Extracellular Matrix: A New Frontier in CancerTherapyCurrent Cancer Drug Targets · Wed,
  7. CDK Inhibition in Lung Cancer Alters Epithelial–Mesenchymal Transition,Autophagy, and MetabolismCurrent Cancer Drug Targets · Tue,
  8. Transformative Advances in the Treatment of Melanoma: A ReviewCurrent Cancer Drug Targets · Tue,
  9. NRF2-Driven CARM1 Promotes Malignant Progression and FerroptosisResistance in Breast CancerCurrent Cancer Drug Targets · Fri,
  10. Comparing Cisplatin Sensitivity in Conventional 2D Versus Biomaterialfree 3D Spheroid Cultures of Human Cancer and Bone Marrow StromalCellsCurrent Cancer Drug Targets · Fri,

About Current Cancer Drug Targets

Current Cancer Drug Targets carries 1,667 indexed papers, 61,196 citations, h-index 111 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Current Cancer Drug Targets sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at http://www.benthamscience.com/ccdt/index.htm.

Use the feed below to follow new Current Cancer Drug Targets publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 108 words.